These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 17883899

  • 1. The protective role of Kangen-karyu against fructose-induced metabolic syndrome in a rat model.
    Yokozawa T, Kim HJ, Yamabe N, Okamoto T, Cho EJ.
    J Pharm Pharmacol; 2007 Sep; 59(9):1271-8. PubMed ID: 17883899
    [Abstract] [Full Text] [Related]

  • 2. Protective effect of Chinese prescription Kangen-karyu and its crude drug Tanjin against age-related lipidosis in rats.
    Cho EJ, Yokozawa T, Okamoto T.
    J Pharm Pharmacol; 2007 May; 59(5):687-94. PubMed ID: 17524234
    [Abstract] [Full Text] [Related]

  • 3. Effects of the Chinese prescription Kangen-karyu and its crude drug Tanjin on ageing process in rats.
    Yokozawa T, Cho EJ, Okamoto T, Sei Y.
    J Pharm Pharmacol; 2006 Dec; 58(12):1591-9. PubMed ID: 17331322
    [Abstract] [Full Text] [Related]

  • 4. The protective role of Chinese prescription Kangen-karyu extract on diet-induced hypercholesterolemia in rats.
    Yokozawa T, Cho EJ, Sasaki S, Satoh A, Okamoto T, Sei Y.
    Biol Pharm Bull; 2006 Apr; 29(4):760-5. PubMed ID: 16595914
    [Abstract] [Full Text] [Related]

  • 5. The protective role of amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model.
    Kim HY, Okubo T, Juneja LR, Yokozawa T.
    Br J Nutr; 2010 Feb; 103(4):502-12. PubMed ID: 19878614
    [Abstract] [Full Text] [Related]

  • 6. Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice.
    Yamabe N, Kim HY, Kang KS, Zhao Q, Matsumoto K, Yokozawa T.
    J Ethnopharmacol; 2010 Jun 16; 129(3):299-305. PubMed ID: 20363309
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effects of Chinese prescription Kangen-karyu on diabetes associated with hyperlipidemia, advanced glycation endproducts, and oxidative stress in streptozotocin-induced diabetic rats.
    Kim HY, Okamoto T, Yokozawa T.
    J Ethnopharmacol; 2009 Jul 15; 124(2):263-9. PubMed ID: 19397970
    [Abstract] [Full Text] [Related]

  • 8. The mechanisms underlying the anti-aging activity of the Chinese prescription Kangen-karyu in hydrogen peroxide-induced human fibroblasts.
    Satoh A, Yokozawa T, Kim YA, Cho EJ, Okamoto T, Sei Y.
    J Pharm Pharmacol; 2005 Oct 15; 57(10):1335-43. PubMed ID: 16259763
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic potential of Chinese prescription Kangen-karyu for patient with lifestyle-induced metabolic syndrome.
    Park CH, Kitazawa T, Futamura A, Hirana H, Shoji M, Osanai M, Yokozawa T.
    Drug Discov Ther; 2020 Nov 04; 14(5):252-255. PubMed ID: 33116040
    [Abstract] [Full Text] [Related]

  • 10. Gravinol ameliorates high-fructose-induced metabolic syndrome through regulation of lipid metabolism and proinflammatory state in rats.
    Yokozawa T, Kim HJ, Cho EJ.
    J Agric Food Chem; 2008 Jul 09; 56(13):5026-32. PubMed ID: 18540612
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic efficacy of Kangen-karyu against H2O2-induced premature senescence.
    Cho EJ, Okamoto T, Yokozawa T.
    J Pharm Pharmacol; 2008 Nov 09; 60(11):1537-44. PubMed ID: 18957176
    [Abstract] [Full Text] [Related]

  • 12. Chinese prescription Kangen-karyu and Salviae Miltiorrhizae Radix improve age-related oxidative stress and inflammatory response through the PI3K/Akt or MAPK pathways.
    Park CH, Kim DH, Park MH, Kim MK, Kim ND, Kim CM, Tanaka T, Yokozawa T, Chung HY, Moon HR.
    Am J Chin Med; 2014 Nov 09; 42(4):987-1005. PubMed ID: 25004887
    [Abstract] [Full Text] [Related]

  • 13. Chinese prescription kangen-karyu ameliorates the development of diabetic hepatic damages via regulating oxidative stress and inflammation in the liver of db/db mice.
    Park CH, Yamabe N, Okamoto T, Toriizuka K, Yokozawa T.
    Biol Pharm Bull; 2011 Nov 09; 34(3):383-8. PubMed ID: 21372389
    [Abstract] [Full Text] [Related]

  • 14. Antioxidative effects related to the potential anti-aging properties of the Chinese prescription Kangen-karyu and Carthami Flos in senescence-accelerated mice.
    Satoh A, Yokozawa T, Cho EJ, Okamoto T, Sei Y.
    Arch Gerontol Geriatr; 2004 Nov 09; 39(1):69-82. PubMed ID: 15158582
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of the Chinese prescription Kangen-karyu against high glucose-induced oxidative stress in LLC-PK1 cells.
    Yokozawa T, Kim YA, Kim HY, Okamoto T, Sei Y.
    J Ethnopharmacol; 2007 Jan 03; 109(1):113-20. PubMed ID: 16949779
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of Chinese prescription Kangen-karyu for dyslipi-demia, using 3T3-L1 adipocytes and type 2 diabetic mice.
    Hum Park C, Young Rhyu D, Sook Noh J, Min Park C, Yokozawa T.
    Drug Discov Ther; 2014 Jun 03; 8(3):121-31. PubMed ID: 25031044
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of Chinese prescription Kangen-karyu for patient with metabolic syndrome.
    Kitazawa T, Park CH, Hiratani K, Choi JS, Yokozawa T.
    Drug Discov Ther; 2020 Mar 08; 14(1):54-57. PubMed ID: 32115440
    [Abstract] [Full Text] [Related]

  • 18. Hepato-/reno-protective activity of Chinese prescription Kangen-karyu through inhibition of AGE formation and fibrosis-related protein expression in type 2 diabetes.
    Okamoto T, Park CH, Noh JS, Toriizuka K, Sei Y, Park JC, Yokozawa T.
    J Pharm Pharmacol; 2011 Jul 08; 63(7):952-9. PubMed ID: 21635261
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of Effects of Chinese Prescription Kangen-karyu on Diabetes-Induced Alterations such as Oxidative Stress and Apoptosis in the Liver of Type 2 Diabetic db/db Mice.
    Park CH, Noh JS, Okamoto T, Park JC, Yokozawa T.
    Evid Based Complement Alternat Med; 2012 Jul 08; 2012():143489. PubMed ID: 22969821
    [Abstract] [Full Text] [Related]

  • 20. Chinese prescription Kangen-karyu prevents dyslipidaemia and oxidative stress in mouse model of type 2 diabetes.
    Noh JS, Park CH, Kim HY, Zhao Q, Yamabe N, Matsumoto K, Yokozawa T.
    J Pharm Pharmacol; 2011 Jan 08; 63(1):111-9. PubMed ID: 21155823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.